Prosecution Insights
Last updated: November 20, 2026

Rayna B Rodriguez, USPTO Patent Examiner

Listed by the USPTO as RODRIGUEZ, RAYNA B

Tech Center 1600 • Art Units: 1628 1692

This examiner grants 33% of resolved cases

Analysis

RODRIGUEZ, RAYNA B is assigned to Technology Center 1600 and art unit 1628. The profile includes 593 resolved cases, a 33.2% allowance rate, and a median of 1,269 days to allowance. The allowance rate indicates that prosecution outcomes in the measured record are more often unresolved in favor of allowance than allowed, while the timing points to a lengthy prosecution cycle.

The interview lift is 19.0%, making interviews a relevant strategic consideration even though the overall allowance rate is limited. Genentech Inc., Janssen Pharmaceutica NV, and Deciphera Pharmaceuticals LLC are recorded companies. The listed firms are COOLEY LLP, BakerHostetler, and Sheppard, Mullin, Richter & Hampton LLP, providing useful context for applicant and counsel activity in the art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

33.2%
Allow Rate
-26.8% vs TC avg
674
Total Applications
+19.0%
Interview Lift
1269
Avg Prosecution Days
Based on 593 resolved cases, 2023–2026

Rejection Statute Breakdown

2.0%
§101 Eligibility
12.9%
§102 Novelty
48.3%
§103 Obviousness
21.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18785844 CDK INHIBITORS Non-Final OA Genentech, Inc.
18544236 METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS Final Rejection Genentech, Inc.
18009682 CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS Final Rejection AMGEN INC.
17599252 OSMOTIC PRESSURE REGULATOR FOR PERITONEAL DIALYSATE CONTAINING D-ALLOSE AND/OR D-ALLULOSE Final Rejection NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
18293475 ANTISEPTIC COMPOSITION Final Rejection OTSUKA PHARMACEUTICAL FACTORY, INC.
17916504 NOVEL FORMUATIONS Final Rejection ARECOR LIMITED
18285136 CRYSTALLINE FORM OF PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Final Rejection SUNSHINE LAKE PHARMA CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Rayna B Rodriguez's allowance rate?

33.2% of resolved applications examined by Rayna B Rodriguez were allowed (593 resolved cases), compared with 25.9% across Art Unit 1628 over the last five years.

Does an interview help with examiner Rayna B Rodriguez?

This examiner's interview lift is +19.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Rayna B Rodriguez take to allow a patent?

Applications allowed by Rayna B Rodriguez took 1,269 days on average from filing to allowance.

Which art unit does examiner Rayna B Rodriguez work in?

Rayna B Rodriguez examines applications in Art Unit 1628 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month